NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma
dc.contributor.author | Hao, M. | |
dc.contributor.author | Franqui-Machin, R. | |
dc.contributor.author | Xu, H. | |
dc.contributor.author | Shaughnessy, J., Jr. | |
dc.contributor.author | Barlogie, B. | |
dc.contributor.author | Roodman, D. | |
dc.contributor.author | Quelle, D. E. | |
dc.contributor.author | Janz, S. | |
dc.contributor.author | Tomasson, M. H. | |
dc.contributor.author | Sanderson, R. D. | |
dc.contributor.author | Qiu, L. | |
dc.contributor.author | Frech, I. | |
dc.contributor.author | Tricot, G. | |
dc.contributor.author | Zhan, F. | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2018-04-23T19:32:50Z | |
dc.date.available | 2018-04-23T19:32:50Z | |
dc.date.issued | 2017-07 | |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Hao, M., Franqui-Machin, R., Xu, H., Shaughnessy, J., Barlogie, B., Roodman, D., … Zhan, F. (2017). NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. Leukemia, 31(7), 1648–1650. http://doi.org/10.1038/leu.2017.115 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/15895 | |
dc.language.iso | en_US | en_US |
dc.publisher | Nature Publishing Group | en_US |
dc.relation.isversionof | 10.1038/leu.2017.115 | en_US |
dc.relation.journal | Leukemia | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/us | |
dc.source | PMC | en_US |
dc.subject | Osteoclasts | en_US |
dc.subject | Multiple myeloma | en_US |
dc.subject | Bone marrow -- Diseases | en_US |
dc.title | NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma | en_US |
dc.type | Article | en_US |